MAXHEALTH - Swing Trade Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Swing Trade Rating: 3.8

📊 Technical & Momentum Analysis

Current Price (₹1,274) is above both 50 DMA (₹1,221) and 200 DMA (₹1,104) — bullish setup.

RSI (56.4) — moderately strong, room for upside but not overbought.

MACD (9.92) — positive momentum, confirms bullish bias.

Volume: Below 1-week average — suggests consolidation, not breakout.

📈 Fundamental Overview

Valuation

P/E (109) vs Industry P/E (69.2) — highly overvalued.

PEG Ratio (4.86) — expensive relative to growth.

Profitability

ROCE (14.9%) and ROE (12.7%) — decent, but not exceptional.

EPS (₹11.1) — modest earnings base for current valuation.

Quarterly Performance

PAT Qtr: ₹319 Cr vs Prev Qtr: ₹291 Cr — solid growth (Qtr Profit Var: +26.8%).

Dividend Yield (0.12%) — negligible income cushion.

Debt-to-Equity (0.32) — moderate leverage, manageable.

FII/DII Holding: Flat to slightly negative — neutral institutional sentiment.

✅ Swing Trade Strategy

Optimal Entry Price: ₹1,240–₹1,255 (near short-term support and 50 DMA).

Target Exit Price: ₹1,310–₹1,325 (near recent high).

Stop Loss: ₹1,210 (below 50 DMA and psychological support).

🧭 If You Already Hold the Stock

Hold for upside toward ₹1,310–₹1,325.

Exit if price breaks below ₹1,210 with volume confirmation or RSI turns downward.

Would you like a scan of other healthcare stocks with stronger earnings and better valuation for swing trading?

Edit in a page